Gefitinib Impurity 73 CAS CATO-C4X-111773

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-111773
Molecular FormulaC11H12O5
Molecular Weight224.21 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Gefitinib Impurity 73 CAS CATO-C4X-111773 chemical structure

Description

As a certified reference material (CRM), Gefitinib Impurity 73 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

CATO supplies Gefitinib Impurity 73 (CAS CATO-C4X-111773), a pharmacopoeial impurity reference standard (molecular formula C11H12O5, MW 224.21 g/mol) used for the identification and quantification of trace impurities in APIs.

Gefitinib Impurity 73 (C11H12O5) contains a carboxylic acid group, a hydroxyl group, an ether linkage, an aromatic ring system. It is notably hygroscopic, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

Physical & Chemical Properties

Molecular FormulaC11H12O5
Molecular Weight224.21 g/mol
AppearanceOff-white to pale yellow crystalline powder
Purity97%+
StorageStore at 2-8°C, protect from light, keep sealed and dry
Solubility (reference)Soluble in methanol, ethanol, DMSO
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)6.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present

Related Gefitinib Standards

Recommended Standards

Why CATO?